ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,277.51
0.80%
US Tech 100
18,064.80
0.02%
Dow Jones
38,686.32
1.51%
Brent Oil
81.295
0.00%
Bitcoin
67,727.48
0.00%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Celyad Oncology SA (CYAD)

  7. Celyad Oncology SA (CYAD) News

CYAD

Celyad Oncology (CYAD)

Celyad Oncology SA
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CYAD
DateTimeSourceHeadlineSymbolCompany
04/04/20241:00AMBusiness WireCelyad Oncology publie ses résultats financiers pour l'année 2023 ainsi que les récents évènements marquantsNASDAQ:CYADCelyad Oncology SA
04/04/20241:00AMBusiness WireCelyad Oncology Reports Full Year 2023 Financial Results and Recent Business HighlightsNASDAQ:CYADCelyad Oncology SA
02/08/20244:01PMBusiness WireCelyad Oncology annonce son intention de mettre fin à ses obligations de déclaration à la SECNASDAQ:CYADCelyad Oncology SA
02/08/20244:01PMBusiness WireCelyad Oncology Announces Intention to Terminate SEC Reporting ObligationsNASDAQ:CYADCelyad Oncology SA
01/17/20246:33AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CYADCelyad Oncology SA
01/16/20244:01PMBusiness WireCelyad Oncology Provides Fourth Quarter 2023 Business Update and 2024 OutlookNASDAQ:CYADCelyad Oncology SA
01/16/20244:01PMBusiness WireCelyad Oncology fait le point sur les activités du quatrième trimestre 2023 et présente ses perspectives pour 2024NASDAQ:CYADCelyad Oncology SA
12/21/20236:19AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CYADCelyad Oncology SA
12/20/20234:01PMBusiness WireCelyad Oncology SA: Publication of a Transparency Notification Received From Fortress Investment Group LLCNASDAQ:CYADCelyad Oncology SA
12/20/20234:01PMBusiness WireCelyad Oncology SA : Publication d’une notification de transparence de Fortress Investment Group LLCNASDAQ:CYADCelyad Oncology SA
12/15/20234:01PMBusiness WireCelyad Oncology: Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)NASDAQ:CYADCelyad Oncology SA
12/15/20234:01PMBusiness WireCelyad Oncology SA : Information relative au Nombre Total de Droits de Vote et d’Actions (Article 15 de la Loi du 2 Mai 2007)NASDAQ:CYADCelyad Oncology SA
12/04/20238:34AMBusiness WireCelyad Announces Management ChangeNASDAQ:CYADCelyad Oncology SA
12/04/20238:34AMBusiness WireCelyad annonce un changement de directionNASDAQ:CYADCelyad Oncology SA
11/30/20234:01PMBusiness WireCelyad Oncology SA : Publication d’une notification de transparence reçue de Tolefi SA (Article 14 §1 de la loi du 2 mai 2007)NASDAQ:CYADCelyad Oncology SA
11/30/20234:01PMBusiness WireCelyad Oncology SA: Publication of a transparency notification received from Tolefi SA (Article 14 §1 of the Law of 2 May 2007)NASDAQ:CYADCelyad Oncology SA
11/21/20234:00PMBusiness WireCelyad Oncology SA : Publication d’une notification de transparence de Fortress Investment Group LLCNASDAQ:CYADCelyad Oncology SA
11/21/20234:00PMBusiness WireCelyad Oncology SA: Publication of a transparency notification received from Fortress Investment Group LLCNASDAQ:CYADCelyad Oncology SA
11/15/20234:37PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CYADCelyad Oncology SA
11/14/20234:00PMBusiness WireCelyad Oncology: Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)NASDAQ:CYADCelyad Oncology SA
11/14/20234:00PMBusiness WireCelyad Oncology SA : Information relative au Nombre Total de Droits de Vote et d’Actions (Article 15 de la Loi du 2 Mai 2007)NASDAQ:CYADCelyad Oncology SA
11/09/20231:00AMBusiness WireCelyad Oncology publie ses résultats financiers pour le troisième trimestre de 2023 ainsi que ses récentes avancéesNASDAQ:CYADCelyad Oncology SA
11/09/20231:00AMBusiness WireCelyad Oncology reports third quarter 2023 financial results and recent business highlightsNASDAQ:CYADCelyad Oncology SA
10/27/20231:45PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CYADCelyad Oncology SA
09/25/20234:01PMBusiness WireCelyad Oncology Announces the Termination of Its American Depository Receipt ProgramNASDAQ:CYADCelyad Oncology SA
09/25/20234:01PMBusiness WireCelyad Oncology annonce l’arrêt de son programme d’American Depositary ReceiptNASDAQ:CYADCelyad Oncology SA
09/18/20236:04AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CYADCelyad Oncology SA
09/15/20234:01PMBusiness WireCelyad Oncology SA : Publication d’une notification de transparence rectifiée de Fortress Investment Group LLCNASDAQ:CYADCelyad Oncology SA
09/15/20234:01PMBusiness WireCelyad Oncology SA: Publication of a Rectified Transparency Notification Received From Fortress Investment Group LLCNASDAQ:CYADCelyad Oncology SA
09/13/20236:29AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CYADCelyad Oncology SA
 Showing the most relevant articles for your search:NASDAQ:CYAD

Your Recent History

USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
FNMA
Fannie Mae (QB)
USOTC
ENZC
Enzolytics (PK)
USOTC
ERHE
ERHC Energy (CE)
NASDAQ
DJT
Trump Media and Technology
USOTC
CIVX
CTR Investments and Cons... (CE)
NASDAQ
AVXL
Anavex Life Sciences
USOTC
ELTP
Elite Pharmaceuticals (QB)
USOTC
BLEG
Branded Legacy (PK)
USOTC
NSAV
Net Savings Link (PK)
USOTC
RNVA
Rennova Health (PK)
NASDAQ
LWLG
Lightwave Logic
NASDAQ
COOP
Mr Cooper
USOTC
NWBO
Northwest Biotherapeutics (QB)
USOTC
DBMM
Digital Brand Media and ... (PK)
USOTC
RDGL
Vivos (QB)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved